Back

Head-to-head comparison of single- versus dual-chamber ICD discriminators for tachyarrhythmia detection: a remote monitoring based, bicentric study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Shocking news regarding implantable cardioverter-defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Flora Diana Gausz

University of Szeged, Szeged (Hungary)

7 More presentations in this session

Presentation thumbnail
Predictors of ICD therapy in cardiac sarcoidosis patients within large metropolitan population
Doctor N. Kim (New York, US) Doctor S. Daoui (New York City, US)
Abstract Slides Video
Presentation thumbnail
Evaluation of defibrillation thresholds in extravascular defibrillators: results from a monocenter prospective study
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Feasibility of extravascular defibrillator implantation in a fully cardiological setting: from general anesthesia to deep sedation, and relevance of surgical back-up
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes after implantable cardioverter-defibrillator therapy in patients with chronic Chagas cardiomyopathy: an updated systematic review and meta-analysis
Doctor I. Ferreira Felix (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Smartpass 2.0 in subcutaneous implantable cardioverter defibrillator: T-wave oversensing no longer the primary cause of inappropriate shocks
Mr C. Monkhouse (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Shocking news regarding implantable cardioverter-defibrillator therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
ICD and remote monitoring
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Late-Breaking Clinical Trials: recent advances in CIED therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources